Gibson Christopher Insider Trading Activity (RXRX)

Profile

Christopher Gibson is the Chief Executive Officer and Director of Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on drug discovery. He has been involved in the company since its early stages, contributing to its innovative approach in integrating technology with biology.

Role	Director
Notability	30/100

Board memberships

Recursion Pharmaceuticals, Inc.

Awards & honors

CEO of Recursion Pharmaceuticals
Led innovative drug discovery initiatives
Contributed to the company's growth in biotechnology

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-05	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale	40.0K	$3.62	$145K
2026-06-05	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition	40.0K	$0.00
2026-05-27	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale	40.0K	$3.08	$123K
2026-05-27	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition	40.0K	$0.00
2026-05-19	RXRX	RECURSION PHARMACEUTICALS, INC.	F — Tax withholding / forfeiture	22.8K	$3.04	$69K
2026-05-08	RXRX	RECURSION PHARMACEUTICALS, INC.	G — Bona-fide gift	20.0K	$0.00
2026-05-08	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale	40.0K	$3.37	$135K
2026-05-08	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition	60.0K	$0.00
2026-04-24	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale	40.0K	$3.61	$144K
2026-04-24	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition	40.0K	$0.00
2026-04-10	PACB	PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	A — Grant or award	57.5K	$0.00
2026-04-08	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	40.0K	$3.10	$124K
2026-04-08	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	40.0K	$0.00
2026-03-25	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	40.0K	$3.25	$130K
2026-03-25	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	40.0K	$0.00
2026-03-11	RXRX	RECURSION PHARMACEUTICALS, INC.	G — Bona-fide gift [10b5-1]	20.0K	$0.00
2026-03-11	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	20.0K	$0.00
2026-03-05	PACB	PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	A — Grant or award	53.9K	$0.00
2026-02-20	RXRX	RECURSION PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	40.0K	$3.46	$138K
2026-02-20	RXRX	RECURSION PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	40.0K	$0.00

Frequently Asked Questions

Who is Gibson Christopher?

How many SEC Form 4 filings has Gibson Christopher submitted recently?

6 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Gibson Christopher been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 23 open-market sales ($7.60M) across all tracked filings.

Where can I see all of Gibson Christopher's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Gibson Christopher — SEC Form 4 Insider Trading Activity

Summary